Vivozon Pharmaceutical Market Cap

Vivozon Pharmaceutical has a market cap or net worth of 196.71 billion as of March 9, 2026. Its market cap has decreased by -50.70% in one year.

Market Cap

196.71B

Enterprise Value

230.67B

Revenue

66.40B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,970.00

Market Cap Chart

Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 196.71B, an increase of 171.51%. That is a compound annual growth rate of 5.04%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	196.71B	-1.98%
Dec 30, 2025	200.68B	-40.93%
Dec 30, 2024	339.73B	134.89%
Dec 28, 2023	144.64B	-2.99%
Dec 29, 2022	149.09B	-19.87%
Dec 30, 2021	186.05B	-37.31%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Organoidsciences	187.36B
OPTUS Pharmaceutical	186.35B
NOVAREX	225.53B
GREEN CROSS WellBeing	168.05B
High Tech Pharm	160.88B
DAE HWA Pharmaceutical	243.48B
Kyung Dong Pharmaceutical	149.53B
DongKoo Bio & Pharma	145.49B

Market Cap Rankings